Suchergebnisse - "Ko, Bor-Sheng"

PubPharm (9)

1

Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance : Interrupted Time Series Analysis

enthalten in: Clinical and translational science | 2020

von Liao, K. | Ko, B. | Chen, L. | +1

2

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients

enthalten in: European journal of haematology | 2018

von Tien, F. | Hou, H. | Tsai, C. | +17

3

Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity

enthalten in: Scientific reports | 2017

von Liang, S. | Lu, Y. | Ko, B. | +4

4

Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study

enthalten in: PloS one | 2015

von Huang, S. | Lin, H. | Yao, M. | +10

5

Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma

enthalten in: Anti-cancer agents in medicinal chemistry | 2013

von Ko, B. | Jan, Y. | Chang, T. | +6

6

Roles of cancer registries in enhancing oncology drug access in the Asia-Pacific region

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2013

von Soon, S. | Lim, H. | Lopes, G. | +9

7

Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review

enthalten in: Medical mycology | 2011

von Liu, J. | Chen, W. | Ko, B. | +5

8

Focal adhesion kinase as a therapeutic target of bortezomib

enthalten in: Anti-cancer agents in medicinal chemistry | 2010

von Ko, B. | Chang, T. | Liou, J.

9

Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B

enthalten in: Life sciences | 2010

von Ko, B. | Chang, T. | Chen, C. | +9

1
[1]